Conestoga Capital Advisors’s Twist Bioscience TWST Stock Holding History

Conestoga Capital Advisors’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.43M	Sell	43,040 -13,745	-24%	-$894K	0.1%	63
2026 Q1	$2.7M	Hold	56,785	–	–	0.05%	62
2025 Q4	$1.8M	Buy	56,785 +1,185	+2%	+$37K	0.03%	72
2025 Q3	$1.56M	Buy	55,600 +27,210	+96%	+$824K	0.03%	77
2025 Q2	$1.04M	Buy	+28,390	New	+$981K	0.02%	85
2020 Q4	–	Sell	-14,275	Closed	-$1.08M	–	149
2020 Q3	$1.08M	Sell	14,275 -21,175	-60%	-$1.32M	0.02%	93
2020 Q2	$1.61M	Buy	35,450 +15,025	+74%	+$539K	0.04%	75
2020 Q1	$625K	Sell	20,425 -4,300	-17%	-$116K	0.02%	88
2019 Q4	$519K	Buy	24,725 +14,800	+149%	+$346K	0.01%	111
2019 Q3	$237K	Buy	9,925 +400	+4%	+$11.6K	0.01%	138
2019 Q2	$276K	Buy	+9,525	New	+$252K	0.01%	132

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Conestoga Capital Advisors's TWST Position: Q2 2026 in Review

Conestoga Capital Advisors reduced its Twist Bioscience (TWST) stake by 24% in Q2 2026, selling an estimated $894K and leaving 43,040 shares worth $4.43M. The position accounts for 0.1% of the portfolio, ranked #63.

Conestoga Capital Advisors first reported a position in TWST in Q2 2019 and has held it in 11 quarters since. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Conestoga Capital Advisors held 43,040 shares of Twist Bioscience worth $4.43M as of Q2 2026.
Conestoga Capital Advisors sold 13,745 Twist Bioscience shares in Q2 2026, an estimated $894K.
Twist Bioscience made up 0.1% of Conestoga Capital Advisors's portfolio in Q2 2026, its #63 holding.
Conestoga Capital Advisors first reported a position in Twist Bioscience in Q2 2019 and has held it in 11 quarters since.
338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Conestoga Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.